Glycolipid alpha-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice. - Wikidata - awgldk - TriplyDB

Glycolipid alpha-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice.

Glycolipid alpha-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice.

http://www.wikidata.org/entity/Q34983932

about

C-galactosylceramide: Synthesis and immunology CD1d- and MR1-Restricted T Cells in Sepsis Discovery of NKT cells and development of NKT cell-targeted anti-tumor immunotherapy Fine tuning a well-oiled machine: Influence of NK1.1 and NKG2D on NKT cell development and function Activation of invariant NKT cells exacerbates experimental visceral leishmaniasis Mechanisms for Glycolipid Antigen-Driven Cytokine Polarization by V 14i NKT Cells Galactose-modified iNKT cell agonists stabilized by an induced fit of CD1d prevent tumour metastasis.NKT TCR Recognition of CD1d- -C-Galactosylceramide Structural Basis for the Recognition of C20:2-αGalCer by the Invariant Natural Killer T Cell Receptor-like Antibody L363 Glycolipids that Elicit IFN-γ-Biased Responses from Natural Killer T Cells Enhanced TCR Footprint by a Novel Glycolipid Increases NKT-Dependent Tumor Protection Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine.α-Galactosylceramide protects swine against influenza infection when administered as a vaccine adjuvant.IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury.A multifactorial mechanism in the superior antimalarial activity of alpha-C-GalCer.Multiple innate signaling pathways cooperate with CD40 to induce potent, CD70-dependent cellular immunity Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis Antigen-specific cytotoxicity by invariant NKT cells in vivo is CD95/CD178-dependent and is correlated with antigenic potency Influenza infection in suckling mice expands an NKT cell subset that protects against airway hyperreactivity.Mouse and human iNKT cell agonist β-mannosylceramide reveals a distinct mechanism of tumor immunity.Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations Preclinical evaluation of invariant natural killer T cells in the 5T33 multiple myeloma model Innate immunity and primary biliary cirrhosis: activated invariant natural killer T cells exacerbate murine autoimmune cholangitis and fibrosis Retinoic acid modulates interferon-γ production by hepatic natural killer T cells via phosphatase 2A and the extracellular signal-regulated kinase pathway Avidity of CD1d-ligand-receptor ternary complex contributes to T-helper 1 (Th1) polarization and anticancer efficacy.Synthesis of C-glycoside analogues of α-galactosylceramide via linear allylic C-H oxidation and allyl cyanate to isocyanate rearrangement.Differential contribution of dendritic cell CD1d to NKT cell-enhanced humoral immunity and CD8+ T cell activation.Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids.C-Glycosphingolipids with an exo-methylene substituent: stereocontrolled synthesis and immunostimulation of mouse and human natural killer T lymphocytes.Endocytic pH regulates cell surface localization of glycolipid antigen loaded CD1d complexes Intradermal NKT cell activation during DNA priming in heterologous prime-boost vaccination enhances T cell responses and protection against Leishmania Connecting the dots: artificial antigen presenting cell-mediated modulation of natural killer T cells.The requirement of CD80, CD86, and ICAM-1 on the ability of adjuvant formulations to potentiate antibody responses to a Plasmodium falciparum blood-stage vaccine.Development of live-attenuated influenza vaccines against outbreaks of H5N1 influenza.NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B-cell lymphoma.Follicular helper NKT cells induce limited B cell responses and germinal center formation in the absence of CD4(+) T cell help.Modulation of invariant natural killer T cell cytokine responses by indoleamine 2,3-dioxygenase NKT cell costimulation: experimental progress and therapeutic promise The bovine CD1D gene has an unusual gene structure and is expressed but cannot present α-galactosylceramide with a C26 fatty acid Natural killer T-cell autoreactivity leads to a specialized activation state

P2860

Q24625835-3CABCEE8-1AEA-4561-9925-3CBE0ACF9CA1 Q26796132-F9EF4CA4-BED2-486A-BEB4-FE39A4A832D2 Q26801584-A2F06759-88E4-4918-82A8-725B63D5C93A Q26830239-A9E4BED2-C2D8-4349-B62B-5777B3419558 Q27318814-11FBCDE6-7908-4DD9-891A-8474E5C946DA Q27658388-1D8C3810-AE62-4CB3-836E-AA1139C67024 Q27667759-7EC743C9-6A6B-453B-A2AD-885089669051 Q27674653-8CCB986A-25E7-4878-89EE-FA4BA25E4464 Q27675769-6BD30267-01BD-4B56-983E-17F7808C1C7E Q27676395-AF8ECF92-233D-4227-A415-269EFAAE8239 Q27679771-AC259DEE-A30C-47F5-8219-87095746BEE3 Q30377447-E2A49368-5299-45F7-8653-CF64EC3D27AE Q30385957-08DED822-B107-4DD3-BAC4-FA1E2F61B60D Q30437432-9A92E2D0-B60E-4090-8B03-7DEB258EB694 Q33570532-0BFEC398-9725-48CA-80F7-FC9E53467B54 Q33653495-12ACB859-C5AC-4B21-B9FD-1DFC95363065 Q34090541-D1AF8634-6274-4B83-B4E9-0CA040DC769D Q34338958-2345241A-66E8-4395-B1F7-A835959DF654 Q34429040-7F12E6CA-698C-4E3E-8A5F-4860A887C209 Q34519826-13B3FEC3-6B6F-4F8D-B4E5-DB07FF00221B Q34641666-54A89EE2-ECD1-4AFF-B256-2009D2CA15D8 Q34761156-CABE3F5A-4297-4C9D-B970-F34FA0876156 Q34790985-62D25ED2-391F-4BDE-800A-1C608CE81289 Q35148930-428CF116-3EED-4745-9D4F-9882FA5EFBD2 Q35409604-E3687121-0934-49BF-9E3D-5D4FFD5B792C Q35686895-994B7FBD-E157-454F-9E2C-A745FD6FDCB8 Q35912977-4B342C57-AA26-452F-A99E-9CE31BE2C0E5 Q35973205-0AA17881-00C5-44BC-BA73-4B5368F31D2E Q36225616-B01980A4-5832-4281-A066-B34CFB57127C Q36249071-C60CE540-F98B-4BE2-A806-5254386ED75E Q36251325-1ADCD0A1-D01C-40F6-9E8F-52CDC833567A Q36383130-6A942E03-547F-45E6-9A81-2FF649B7CB24 Q36398927-840FD9F6-E2BE-4F38-80B1-E4F22FE61406 Q36482772-141ABB54-FA45-4516-863B-0E1217841FD1 Q36568780-0D4BD8B3-C994-491E-9DE4-052804AD45F3 Q36573926-30657D15-9C0A-4E34-A301-A2FA4758000D Q36632492-D496ECB7-0165-4AAB-8650-33BD24172AE1 Q36739843-E3EFA913-50C0-4B2D-A384-4733DBF629B2 Q36749511-297ECD18-EB2A-44A9-86FC-0AFCFDC390D7 Q36969739-113C2A83-9A19-49F4-87D5-4591B7174005

P2860

Glycolipid alpha-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice.

http://www.wikidata.org/entity/Q34983932

description

2006 nî lūn-bûn

@nan

2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Glycolipid alpha-C-galactosylc ...... tive immune responses of mice.

@ast

Glycolipid alpha-C-galactosylc ...... tive immune responses of mice.

@en

Glycolipid alpha-C-galactosylc ...... tive immune responses of mice.

@nl

type

label

Glycolipid alpha-C-galactosylc ...... tive immune responses of mice.

@ast

Glycolipid alpha-C-galactosylc ...... tive immune responses of mice.

@en

Glycolipid alpha-C-galactosylc ...... tive immune responses of mice.

@nl

prefLabel

Glycolipid alpha-C-galactosylc ...... tive immune responses of mice.

@ast

Glycolipid alpha-C-galactosylc ...... tive immune responses of mice.

@en

Glycolipid alpha-C-galactosylc ...... tive immune responses of mice.

@nl

P1433

Q34983932-3B874082-071A-4E5A-9452-DDEB94565562

P1476

Q34983932-00AF8AFE-A84A-4B11-9BC8-05683496FA30

P2093

Q34983932-15DE9708-9CBA-4CA4-990B-55804FA01608

Q34983932-177416E7-C2CD-4A02-932E-B9A4900EB142

Q34983932-2C796E30-5DCA-4E81-B796-CD7AD0B0D4EE

Q34983932-4AE9E946-8B34-463E-BDCD-17A5F8DB1507

Q34983932-EA32519D-5E5C-4179-929D-D1ED8082EEDC

Q34983932-F217533B-1213-46D1-B17B-A9727665ECF4

Q34983932-F36E6C63-4C00-47B1-B3D2-BF1AF093EBB3

Q34983932-F478677F-14E5-4F32-9C51-0CF941D2D9C4

P2860

Q34983932-107AA1DA-8B0E-4EBB-9A1D-8B993B4339C5

Q34983932-13D17689-93BC-4715-8D5F-A0541B134382

Q34983932-17B77E1D-5ADB-4D5D-B1E7-BA3D788B0834

Q34983932-1F72C806-719B-440D-92E1-0194C8C9C456

Q34983932-249091CD-DA65-4C93-8F43-F424B600E852

Q34983932-2B38838C-D593-4CF9-9BCF-70EF7CA5652F

Q34983932-41D23B59-84BE-482D-AE9A-EB1E17B66762

Q34983932-541661A0-1374-42D3-A0B9-1D69B488BBE2

Q34983932-56306457-2188-4F7B-AA13-58AC160946C4

Q34983932-68FEE1BB-F919-4FF3-AC92-BC8F26C96400

P304

Q34983932-D6F65F18-6B30-439E-B28E-7066D50E6222

P31

Q34983932-AFCD34DA-3E9F-415A-8F3B-483F6479C8A9

P356

Q34983932-E61D4C0E-2D66-4D43-B8A5-ED921C388E47

P407

Q34983932-783FB2AD-A150-417F-8029-E66A4858397D

P433

Q34983932-666E55AF-34DF-45CD-889B-5B44709F8BBE

P478

Q34983932-D5BB43A7-FD27-4AE3-AA6A-67A9007D1F41

P50

Q34983932-A7F55D75-7B62-4B19-8670-53BE7B5C9DC5

P577

Q34983932-6B71D805-B49F-4A0C-9447-B3A5ECB58FF1

P5875

Q34983932-78DB23E5-94BC-4CEF-98E1-38CC08ECF182

P698

Q34983932-4AF359EE-EC31-472D-8258-38CA303A9CFB

P932

Q34983932-0C19CA08-1AB3-460D-9DAF-82CE76155E5A

P356

PNAS.0604812103

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Glycolipid alpha-C-galactosylc ...... tive immune responses of mice.

@en

P2093

Anthony J Bonito

http://www.w3.org/2001/XMLSchema#string

Guangwu Chen

http://www.w3.org/2001/XMLSchema#string

Hiroaki Hemmi

http://www.w3.org/2001/XMLSchema#string

Kanako Shimizu

http://www.w3.org/2001/XMLSchema#string

Mikiko Fukui

http://www.w3.org/2001/XMLSchema#string

Ralph M Steinman

http://www.w3.org/2001/XMLSchema#string

Richard W Franck

http://www.w3.org/2001/XMLSchema#string

Shin-Ichiro Fujii

http://www.w3.org/2001/XMLSchema#string

P2860

Sustained expansion of NKT cells and antigen-specific T cells after injection of alpha-galactosyl-ceramide loaded mature dendritic cells in cancer patients.

Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells

Glycolipid activation of invariant T cell receptor+ NK T cells is sufficient to induce airway hyperreactivity independent of conventional CD4+ T cells.

The regulatory role of Valpha14 NKT cells in innate and acquired immune response.

The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies

The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo.

Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines.

A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma

Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein.

Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-Galactosylceramide

P304

11252-11257

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0604812103

http://www.w3.org/2001/XMLSchema#string

P407

P433

30

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-07-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6940603

http://www.w3.org/2001/XMLSchema#string

P698

16844772

http://www.w3.org/2001/XMLSchema#string

P932

1544074

http://www.w3.org/2001/XMLSchema#string